Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,077 | 71,478,823 | 0.68% | -0.27% | -3.40% | -4.14% | -2.49% | 23.35% |
| Healthcare | HEALTHCARE | Sector | 1,141 | 6,864,215 | 0.86% | 1.30% | -4.50% | -4.17% | 3.50% | 13.53% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 589 | 3,821,332 | 1.08% | 2.76% | -2.07% | 4.72% | 17.30% | 39.35% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 281 | 1,485,360 | 2.46% | 3.43% | -2.56% | -4.68% | 12.95% | 30.89% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 91 | 150,732 | 0.71% | 1.95% | 4.39% | 6.74% | 24.30% | 59.94% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 4,379 | 0.76% | 6.22% | 52.66% | 105.19% | 117.21% | 402.44% |
| Relmada Therapeutics, Inc. | RLMD:USARLMD:USA | Stock | 1 | 745 | 2.01% | 6.61% | 52.03% | 47.00% | 228.70% | >999.99% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 2,319 | 1.70% | -6.90% | 39.45% | 2.83% | 14.54% | -64.25% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 5,410 | -2.51% | 2.02% | 29.46% | 26.48% | 44.91% | 85.02% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 2,929 | -0.17% | -4.64% | 23.97% | -7.46% | 44.80% | 96.10% |
| Solid Biosciences, Inc. | SLDB:USASLDB:USA | Stock | 1 | 726 | 2.50% | 2.07% | 23.83% | 30.85% | 25.72% | 114.22% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 5,787 | -0.88% | 19.34% | 20.03% | 25.27% | 14.36% | 7.75% |
| Capricor Therapeutics, Inc. | CAPR:USACAPR:USA | Stock | 1 | 1,732 | -0.92% | 0.74% | 16.56% | 4.37% | 285.17% | 217.89% |
| Definium Therapeutics, Inc. | DFTX:USADFTX:USA | Stock | 1 | 2,029 | 8.99% | 11.53% | 16.45% | 53.85% | 67.07% | 271.84% |
| Alto Neuroscience, Inc. | ANRO:USAANRO:USA | Stock | 1 | 727 | 4.14% | 13.26% | 16.41% | 31.52% | 475.18% | >999.99% |
| MapLight Therapeutics, Inc. | MPLT:USAMPLT:USA | Stock | 1 | 909 | 2.46% | 14.83% | 15.66% | 18.59% | N/A | N/A |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 3,484 | 5.21% | 3.76% | 15.03% | 33.55% | 114.64% | 64.63% |
| Entrada Therapeutics, Inc. | TRDA:USATRDA:USA | Stock | 1 | 512 | 6.81% | 11.87% | 13.76% | 31.13% | 129.25% | 53.88% |
| Rapport Therapeutics, Inc. | RAPP:USARAPP:USA | Stock | 1 | 1,460 | 1.21% | 9.66% | 13.72% | 4.38% | 10.46% | 231.28% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 5,669 | 0.39% | 8.63% | 11.37% | 12.03% | 42.30% | 64.17% |
| Hyperliquid Strategies, Inc. | PURR:USAPURR:USA | Stock | 1 | 652 | 0.79% | -2.66% | 10.32% | 44.10% | -79.60% | -19.21% |
| Design Therapeutics, Inc. | DSGN:USADSGN:USA | Stock | 1 | 679 | 3.48% | 2.61% | 10.10% | 17.38% | 62.15% | 205.41% |
| Prothena Corp. Plc | PRTA:USAPRTA:USA | Stock | 1 | 540 | 3.19% | 7.73% | 7.16% | 5.03% | 1.11% | -14.57% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 5,449 | 0.91% | 3.00% | 6.77% | -9.49% | 10.87% | 47.53% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 8,458 | 1.63% | 6.18% | 4.71% | -5.95% | 44.88% | 53.83% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 91 | 150,732 | 0.71% | 1.95% | 4.39% | 6.74% | 24.30% | 59.94% |
| LB Pharmaceuticals, Inc. | LBRX:USALBRX:USA | Stock | 1 | 711 | 0.61% | 2.48% | 3.76% | 11.46% | 57.42% | N/A |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 3,031 | 0.24% | 4.29% | 3.76% | 6.34% | 18.70% | 3.76% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 13,217 | 0.62% | 1.09% | 1.08% | -6.54% | -3.24% | 23.89% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 11,604 | -0.41% | -0.43% | 0.86% | 10.75% | 37.52% | 50.63% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 8,751 | -0.90% | 2.36% | 0.33% | 8.33% | 502.19% | 790.10% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 26,945 | 0.25% | -2.85% | -0.13% | 4.43% | 19.17% | 39.20% |
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 3,766 | 0.27% | 1.41% | -0.80% | -16.44% | 5.08% | 36.76% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,610 | -0.18% | 1.34% | -1.10% | -25.28% | 3.86% | -13.76% |
| Annexon, Inc. | ANNX:USAANNX:USA | Stock | 1 | 860 | -3.25% | -0.09% | -1.29% | 6.77% | 76.90% | 196.13% |
| Arrowhead Pharmaceuticals, Inc. | ARWR:USAARWR:USA | Stock | 1 | 8,811 | 0.35% | 3.54% | -1.84% | -5.23% | 79.72% | 415.53% |
| Soleno Therapeutics, Inc. | SLNO:USASLNO:USA | Stock | 1 | 1,951 | 10.48% | 16.17% | -1.94% | -20.11% | -38.47% | -45.81% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,001 | 95,947,662 | 0.75% | -0.24% | -3.42% | -3.65% | -1.42% | 18.14% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 913 | 4.69% | 7.84% | -3.79% | 15.91% | 8.47% | 36.80% |
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 1,238 | -3.58% | -5.90% | -4.86% | -21.64% | 35.53% | 240.71% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 1,827 | -1.75% | -5.33% | -5.30% | 0.79% | 35.61% | 413.48% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 2,950 | -0.48% | 2.76% | -5.72% | 3.50% | 7.08% | 62.37% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 1,397 | 13.71% | 11.73% | -9.84% | -14.79% | -35.09% | -57.43% |
| Bright Minds Biosciences, Inc. | DRUG:USADRUG:USA | Stock | 1 | 729 | -1.71% | -3.21% | -10.35% | -8.10% | 23.76% | 98.62% |
* Colors indicate performance relative to the benchmark.